Mode
Text Size
Log in / Sign up

Social prescribing may improve loneliness and quality of life in older adults with anxiety and depressionSocial Prescribing May Help Older Adults With Anxiety and Depression

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that social prescribing may improve quality of life and loneliness in older adults, though high-quality trial data is limited.

This narrative review examines the potential of social prescribing, which involves connecting individuals with non-clinical community resources, to improve mental health outcomes in older adults. The review focuses on outcomes including loneliness, social participation, quality of life, and specific depressive outcomes. The authors suggest that social prescribing may offer potential benefits for these areas in older adults with anxiety and depression.

Several limitations are noted, including a scarcity of high-quality trials specifically enrolling older adults with diagnosed anxiety or depressive disorders. The authors also highlight significant variability in the definitions of social prescribing, intervention intensity, and outcome measures. Furthermore, several proposed mechanisms for these improvements are supported by indirect evidence rather than formal mediation analyses.

Clinical utility depends on several factors, including risk stratification, shared decision-making, relational support, and access to community resources. The authors emphasize the need for closed-loop evaluation to determine the effectiveness of these programs. Due to the scarcity of high-quality trials and the indirect nature of the evidence for underlying mechanisms, the clinical certainty of these findings is currently limited.

How this fits prior evidence

This narrative review addresses a gap in evidence regarding non-pharmacological interventions for older adults. While prior coverage noted that non-pharmacological interventions significantly improve depression, anxiety, and sleep quality in maintenance hemodialysis patients, this review specifically explores social prescribing for older adults with anxiety and depression. It complements the finding that digital interventions like EASE and MR showed no significant difference in anxiety and depression by exploring community-based, non-clinical pathways.

This review looked at social prescribing, which involves connecting people to non-clinical community resources. The review focused on how these programs might help older adults who are experiencing anxiety or depression. Researchers looked at several factors, including feelings of loneliness, levels of social participation, and overall quality of life.

The review found that social prescribing has the potential to improve these areas for older adults. However, the evidence is currently limited. Many of the findings are based on indirect evidence rather than direct clinical trials. There are also many different ways that social prescribing programs are designed and measured, which makes it hard to compare them directly.

Because high-quality trials specifically for older adults with diagnosed disorders are still scarce, these results should be viewed as preliminary. The success of these programs often depends on having a strong support system and access to local resources. Talk to your doctor to see if these types of community programs are a good fit for your specific needs.

What this means for you:
Social prescribing may improve quality of life for older adults, but more high-quality research is needed.

Common questions

What is social prescribing for older adults?

Social prescribing involves connecting individuals to non-clinical community resources. For older adults, these programs aim to improve quality of life and social participation. The goal is to address issues like loneliness and depressive outcomes by linking people to local support systems and community activities.

Can social prescribing help with anxiety and depression?

The review suggests that social prescribing has potential benefits for those with anxiety and depression. It may specifically help with loneliness and social participation. However, because high-quality trials for these specific conditions in older adults are currently scarce, the evidence is still developing.

Is social prescribing a proven treatment for mental health?

While the review shows potential benefits for quality of life and depressive outcomes, it is not a replacement for clinical treatment. Because many mechanisms are supported by indirect evidence rather than formal analysis, you should consult your doctor to discuss how these programs fit into your care.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Population ageing and the rising burden of multimorbidity require late-life anxiety and depression to be addressed beyond symptom control. Loneliness, social isolation, restricted activity, and loss of meaningful roles frequently interact with physical illness and functional decline; however, these determinants are not readily modified through conventional clinical care alone. Social prescribing offers a range of supported pathways through which health and care professionals connect individuals with non-clinical community resources, ranging from light-touch referrals to more holistic, relationally supported models. This narrative review used a structured literature search and an explicit evidence framework to distinguish between direct evaluations of social prescribing services, pathway-level evidence on constituent activities and mechanisms, and implementation evidence concerning referral, connector support, and community capacity. Current findings suggest the potential benefits for loneliness, social participation, quality of life, and selected depressive outcomes through strengthened social connections, behavioural activation, physical activity, engagement with nature and culture, and the restoration of valued social identities. Nevertheless, high-quality trials specifically enrolling older adults with diagnosed anxiety or depressive disorders remain scarce. Definitions of social prescribing, intervention intensity, comparators, and outcome measures vary substantially, while several proposed mechanisms are supported by indirect evidence rather than formal mediation analyses. Effectiveness, therefore, depends not only on the activity offered but also on appropriate risk stratification, shared decision-making, sufficient relational support when required, accessible community resources, and closed-loop evaluation. Future research should use complex intervention and implementation science frameworks to identify appropriate populations, core and adaptable components, causal mediators, cost-effectiveness, and equitable models that can be embedded within local primary care and ageing service systems.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.